Fig. 6: Immunotherapy increases the survival rate of patients with Act and Inf phenotypes.
From: The responses of HNSCC patients to immunotherapy are shown by two novel co-expression patterns
Pearson-correlation plots between overall survival (months) post-treatment (with anti-PD-1/PD-L1 inhibitors) and the amplitudes of Act phenotype as computed for each patient (left panel). Increased Act phenotype (=more negative values) is associated with higher survival. The subpopulation of superior survivors—which is outlined in the left panel—was plotted further against the Inf phenotypic amplitudes (right panel).
